EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Bioprosthetic Aortic Valve Degeneration After TAVR and SAVR: Incidence, Diagnosis, Predictors, and Management

Nadera N Bismee iD, Niloofar Javadi, Ahmed Khedr iD, Fatma Omar, Kamal Awad, Mohammed Tiseer Abbas iD, Isabel G Scalia iD, Milagros Pereyra iD, George Bcharah iD, Juan M Farina iD, Chadi Ayoub, Kristen A Sell-Dottin und 1 weitere

Journal of Cardiovascular Development and Disease · 30.11.2024 · 11 (12) · 384

DOI: 10.3390/jcdd11120384 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Cardiovascular Development and Disease, online erschienen am 30.11.2024. Verfasst von Nadera N Bismee und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, Mayo Clinic, Phoenix, AZ 85054, USA. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bioprosthetic aortic valve degeneration (BAVD) is a significant clinical concern following both transcatheter aortic valve replacement (TAVR) and surgical aortic valve replacement (SAVR). The increasing use of bioprosthetic valves in aortic valve replacement in younger patients and the subsequent rise in cases of BAVD are acknowledged in this review which aims to provide a comprehensive overview of the incidence, diagnosis, predictors, and management of BAVD. Based on a thorough review of the existing literature, this article provides an updated overview of the biological mechanisms underlying valve degeneration, including calcification, structural deterioration, and inflammatory processes and addresses the various risk factors contributing to BAVD, such as patient demographics, comorbidities, and procedural variables. The difficulties in early detection and accurate diagnosis of BAVD are discussed with an emphasis on the need for improved imaging techniques. The incidence and progression of BAVD in patients undergoing TAVR versus SAVR are compared, providing insights into the differences and similarities between the two procedures and procedural impacts on valve longevity. The current strategies for managing BAVD, including re-intervention options of redo surgery and valve-in-valve TAVR, along with emerging treatments are discussed. The controversies in the existing literature are highlighted to offer directions for future investigations to enhance the understanding and management of BAVD.

Schlagwörter

Stichwörter der Autor:innen

aortic stenosisaortic valve replacementbioprosthetic aortic valvestructural valve degeneration

Autor:innen und Institutionen

  • Department of Cardiovascular Medicine, Mayo Clinic, Phoenix, AZ 85054, USA.
  • Department of Cardiovascular Surgery, Mayo Clinic, Phoenix, AZ 85054, USA.
  • Mayo Clinic Alix School of Medicine, Phoenix, AZ 85054, USA.

ORCID-Profile: Nadera N Bismee, Ahmed Khedr, Mohammed Tiseer Abbas, Isabel G Scalia, Milagros Pereyra, George Bcharah, Juan M Farina, Reza Arsanjani

Zitieren

APA

Bismee, N. N., Javadi, N., Khedr, A., Omar, F., Awad, K., Abbas, M. T., Scalia, I. G., Pereyra, M., Bcharah, G., Farina, J. M., Ayoub, C., Sell-Dottin, K. A., & Arsanjani, R. (2024). Bioprosthetic Aortic Valve Degeneration After TAVR and SAVR: Incidence, Diagnosis, Predictors, and Management. Journal of Cardiovascular Development and Disease, 11(12), 384. https://doi.org/10.3390/jcdd11120384

Vancouver

Bismee NN, Javadi N, Khedr A, Omar F, Awad K, Abbas MT, et al. Bioprosthetic Aortic Valve Degeneration After TAVR and SAVR: Incidence, Diagnosis, Predictors, and Management. Journal of Cardiovascular Development and Disease. 2024;11(12):384. doi:10.3390/jcdd11120384

BibTeX
@article{Bismee2024,
  author = {Bismee, Nadera N and Javadi, Niloofar and Khedr, Ahmed and Omar, Fatma and Awad, Kamal and Abbas, Mohammed Tiseer and Scalia, Isabel G and Pereyra, Milagros and Bcharah, George and Farina, Juan M and Ayoub, Chadi and Sell-Dottin, Kristen A and Arsanjani, Reza},
  title = {Bioprosthetic Aortic Valve Degeneration After TAVR and SAVR: Incidence, Diagnosis, Predictors, and Management},
  journal = {Journal of Cardiovascular Development and Disease},
  year = {2024},
  volume = {11},
  number = {12},
  pages = {384},
  doi = {10.3390/jcdd11120384}
}
Kostenlos starten →